Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MEDICINES360

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 28
  • 0 comments

FDA approve LEVONORGESTREL

Comment Full text

MARINUS

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 32
  • 0 comments

FDA approve GANAXOLONE

Comment Full text

SEATTLE GENETICS

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 26
  • 0 comments

FDA approve BRENTUXIMAB VEDOTIN

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 26
  • 0 comments

FDA approve ETANERCEPT-SZZS

Comment Full text

EISAI INC

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 26
  • 0 comments

FDA approve LENVATINIB MESYLATE

Comment Full text

KOWA CO

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 28
  • 0 comments

FDA approve PITAVASTATIN CALCIUM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 31
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

YABAO PHARM

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 26
  • 0 comments

FDA approve SORAFENIB TOSYLATE

Comment Full text

PFIZER

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 24
  • 0 comments

FDA approve OXAPROZIN POTASSIUM

Comment Full text

PFIZER

  • FDA Approval
  • Nov. 11, 2022, 22:53 UTC
  • 26
  • 0 comments

FDA approve PIROXICAM

Comment Full text
  • Previous
  • 942
  • 943
  • 944
  • 945
  • 946
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(268431)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156297)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin